Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China By Investing.com

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) — Cytokinetics (NASDAQ:), Incorporated…

www.investing.com

More posts

Market Volatility Tempting You to Get Out? Read This First

February 5, 2025
New designs unveiled for Baltimore’s Francis Scott Key Bridge replacement almost a year after deadly ship strike and collapse

February 5, 2025
Spain says Palestinians must stay in Gaza, rejecting Trump's proposal to resettle them

February 5, 2025
Australia, Japan, Philippines, US to conduct maritime cooperative activity

February 5, 2025